InvestorsHub Logo
Followers 98
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

Re: None

Thursday, 02/25/2016 4:29:20 PM

Thursday, February 25, 2016 4:29:20 PM

Post# of 346429
Clearly SUNRISE was tampered with also.

The interim analysis showed that the bavituximab combination group is performing as expected according to the original trial assumptions in terms of overall survival, while the docetaxel group is dramatically outperforming overall survival expectations based on the original trial assumptions and as compared to recently published studies

Now I pray the whole thing is sold for 4/share by years end.

Bavituximab the essential key to a cure for cancer needed by all pharmaceutical companies.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News